Avecho Biotechnology Ltd has released a press release.
Phase I clinical trial testing CBD product-enrolment begins
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- June 2021 Quarterly Activities Report & Appendix 4C
- Avecho to Present New CBD Data at GCI Virtual Summit
- Chairs Address and CEO Presentation
- AB Vista to explore new TPM applications for Animal Health
- TGA meeting for CBD soft-gel targeting insomnia
Later from Avecho Biotechnology
- Dosing begins in Phase I PK trial testing CBD soft-gel
- Topical CBD pain study with Lambert Initiative approved
- September 2021 Quarterly Activities Report & Appendix 4C
- Positive results from Avechos Phase I trial of CBD soft-gel
- AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology